Literature DB >> 18940918

Clinical decision support tools: personal digital assistant versus online dietary supplement databases.

Kevin A Clauson1, Hyla H Polen, Amy S Peak, Wallace A Marsh, Sandra L DiScala.   

Abstract

BACKGROUND: Clinical decision support tools (CDSTs) on personal digital assistants (PDAs) and online databases assist healthcare practitioners who make decisions about dietary supplements.
OBJECTIVE: To assess and compare the content of PDA dietary supplement databases and their online counterparts used as CDSTs.
METHODS: A total of 102 question-and-answer pairs were developed within 10 weighted categories of the most clinically relevant aspects of dietary supplement therapy. PDA versions of AltMedDex, Lexi-Natural, Natural Medicines Comprehensive Database, and Natural Standard and their online counterparts were assessed by scope (percent of correct answers present), completeness (3-point scale), ease of use, and a composite score integrating all 3 criteria. Descriptive statistics and inferential statistics, including a chi(2) test, Scheffé's multiple comparison test, McNemar's test, and the Wilcoxon signed rank test were used to analyze data.
RESULTS: The scope scores for PDA databases were: Natural Medicines Comprehensive Database 84.3%, Natural Standard 58.8%, Lexi-Natural 50.0%, and AltMedDex 36.3%, with Natural Medicines Comprehensive Database statistically superior (p < 0.01). Completeness scores were: Natural Medicines Comprehensive Database 78.4%, Natural Standard 51.0%, Lexi-Natural 43.5%, and AltMedDex 29.7%. Lexi-Natural was superior in ease of use (p < 0.01). Composite scores for PDA databases were: Natural Medicines Comprehensive Database 79.3, Natural Standard 53.0, Lexi-Natural 48.0, and AltMedDex 32.5, with Natural Medicines Comprehensive Database superior (p < 0.01). There was no difference between the scope for PDA and online database pairs with Lexi-Natural (50.0% and 53.9%, respectively) or Natural Medicines Comprehensive Database (84.3% and 84.3%, respectively) (p > 0.05), whereas differences existed for AltMedDex (36.3% vs 74.5%, respectively) and Natural Standard (58.8% vs 80.4%, respectively) (p < 0.01). For composite scores, AltMedDex and Natural Standard online were better than their PDA counterparts (p < 0.01).
CONCLUSIONS: Natural Medicines Comprehensive Database achieved significantly higher scope, completeness, and composite scores compared with other dietary supplement PDA CDSTs in this study. There was no difference between the PDA and online databases for Lexi-Natural and Natural Medicines Comprehensive Database, whereas online versions of AltMedDex and Natural Standard were significantly better than their PDA counterparts.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18940918     DOI: 10.1345/aph.1L297

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  5 in total

1.  A pilot study to compare natural health product-drug interactions in two databases in Canada.

Authors:  Guillaume Faubert; Denis Lebel; Jean-François Bussières
Journal:  Pharm World Sci       Date:  2010-01-14

2.  Evaluating the value of a web-based natural medicine clinical decision tool at an academic medical center.

Authors:  Sue Boehmer; Kelly Karpa
Journal:  BMC Health Serv Res       Date:  2011-10-19       Impact factor: 2.655

3.  eHealth technologies assisting in identifying potential adverse interactions with complementary and alternative medicine (CAM) or standalone CAM adverse events or side effects: a scoping review.

Authors:  Jeremy Y Ng; Maryam Mooghali; Vanessa Munford
Journal:  BMC Complement Med Ther       Date:  2020-07-29

4.  Web-based online resources about adverse interactions or side effects associated with complementary and alternative medicine: a systematic review, summarization and quality assessment.

Authors:  Jeremy Y Ng; Vanessa Munford; Harmy Thakar
Journal:  BMC Med Inform Decis Mak       Date:  2020-11-09       Impact factor: 2.796

5.  Questions about complementary and alternative medicine to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive pilot study.

Authors:  Jan Schjøtt; Hilde Erdal
Journal:  BMC Complement Altern Med       Date:  2014-02-14       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.